ArticleMolecular therapy oncolytics2023

Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1.

Dmitry V Chouljenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.